January 29, 2026 Executing GLP BSL-3 Studies: Supporting Vaccine and Antiviral Clinical Trials Through Reliable Virus-Related Clinical Sample Testing
January 27, 2026 Bridging Discovery and Translational Science: Why Infectious Disease Programs Need Integrated In Vitro and In Vivo Models
January 21, 2026 Why Neutralization Assays Still Matter: Southern Research’s Approach to Robust, Reproducible Virology Assays for Modern Drug Programs
January 19, 2026 Inside Southern Research’s BSL-2 and BSL-3 Capabilities: What Sponsors Should Know About GCLP-Ready Infectious Disease Studies
December 11, 2025 Scaling Drug Discovery: The Benefits of Custom Screening Solutions for Large Pharma
October 30, 2025 Why Turnaround Time Is Crucial for Biotech: Accelerating Preclinical Development Without Compromising Quality
